REAL WORLD EVIDENCE ON CLINICAL OUTCOMES WITH AZTREONAM-AVIBACTAM (ATM-AVI)

REAL WORLD EVIDENCE ON CLINICAL OUTCOMES WITH AZTREONAM-AVIBACTAM (ATM-AVI)

Individual projects requesting up to $50,000 USD will be considered. The total budget for this RFP is $ 250,000 USD. Maximum project length is 12 months. - Tuesday, April 28, 2026

Pfizer
This RFP invites research proposals aimed at assessing clinical outcomes associated with the use of Aztreonam- Avibactam (ATM-AVI) in real world clinical settings.

Funding Opportunity

Visit the funding page (members only, sign in): REAL WORLD EVIDENCE ON CLINICAL OUTCOMES WITH AZTREONAM-AVIBACTAM (ATM-AVI)

Sign in or register for free to read the full details and apply

Sign in Create a free account

Share:

All funding opportunities